Replies to post #9339 on Seelos Therapeutics Inc (SEEL)

[markkind]

So is the Swiss issue similar to the Abbot issue in CN

Hopefully the Swiss offered a path similar Repsonse Letter APRI recieved in CN

[eicoman]

there are other countries especially in Africa that depend on Swiss Medic for approval of drugs, so I wonder if that was a consideration by Swiss Medic, APRI has indicated that those areas with hot climates and less distribution systems would be targeted for the room temp version only, such as Africa, Mid-east, maybe areas of Latin America. The key for sales in the short term are the 10 approved countries, if France, Germany, Italy and Spain had Vitaros selling people in Switzerland could certainly get it.